Cell-Sheet Immunoisolation Device with Porous Membrane-Hydrogel Layers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing immunoisolation devices face challenges in balancing membrane thickness with durability and permeability, leading to issues such as decreased permeability due to protein adsorption and tissue adhesion, and immune rejection when using allogeneic cells.

Innovation Solution

An immunoisolation device comprising a sheet-like cell aggregate covered by an immunoisolation layer, which includes a porous membrane or fiber structure, and a hydrogel, with a thickness of 300 μm or less, to enhance permeability and durability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the immunoisolation layer is made thinner to reduce diffusion distance and improve permeability, then the permeability of substances such as physiologically active substances and nutrients is improved, but the durability and membrane strength decrease, making the device more likely to break or twist

Engineering Contradiction:
ImprovepermeabilityVSAvoidmembrane strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent applies composite materials by combining multiple materials with different properties to create the immunoisolation layer. Specifically, it uses a multilayer structure comprising a porous membrane layer (made from materials like polyvinylidene fluoride, polyether sulfone, or polycarbonate) and a hydrogel layer (made from materials like polyacrylamide, polyethylene glycol, or alginate). This composite structure allows the device to achieve both high permeability (from the porous membrane) and sufficient durability (from the combined layers), resolving the contradiction between thinning the membrane for permeability and maintaining strength for durability.

Inventive Principle:
Principle #40Composite materials

2Strength

If the cell cluster diameter exceeds 500 μm to maintain structural integrity, then the membrane strength is improved, but internal necrosis of cell clusters occurs due to insufficient permeability

Engineering Contradiction:
Improvemembrane strengthVSAvoidcell viability
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The patent applies local quality by creating a multilayer structure where each layer has specific local properties optimized for its function. The porous membrane layer provides mechanical strength and structural integrity, while the hydrogel layer provides high porosity and excellent permeability properties. This local differentiation of properties within the immunoisolation layer allows the device to maintain structural integrity while ensuring sufficient permeability to prevent cell necrosis, resolving the contradiction between membrane strength and cell viability.

Inventive Principle:
Principle #3Local quality

3Adaptability or versatility

If allogeneic cells are used for transplantation to expand cell sources, then cell availability is improved, but immune rejection occurs due to lack of HLA homology

Engineering Contradiction:
Improvecell source availabilityVSAvoidimmune rejection
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies the intermediary principle by introducing the immunoisolation layer as a mediator between the allogeneic transplanted cells and the host immune system. This multilayer structure (porous membrane + hydrogel) acts as a physical barrier that prevents immune cells and antibodies from contacting the transplanted cells, while still allowing nutrients and physiologically active substances to pass through. This enables the use of allogeneic cells (expanding cell source availability) without immune rejection, as the immunoisolation layer mediates the interaction between donor and host.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device achieves reduced diffusion distance for physiologically active substances and nutrients while improving durability for long-term transplantation, and provides immune control using a cell sheet.

Implementation Method 1

the devices allow for easy permeation of oxygen and/or nutritional components to transplanted cells; the devices allow for easy release of a desired physiologically active substance (cytokines, hormones, growth factors, etc.) from cells

Methodology Applied
Scientific EffectPermeation: Permeation

Implementation Method 2

Many immunoisolation devices using porous membranes have been studied

Methodology Applied
Scientific EffectPorosity: Porosity

Implementation Method 3

permeation of immunoresponsive cells and immune response factors is prevented

Methodology Applied
Scientific EffectImmunoisolation:

Implementation Method 4

achieves both a reduction in diffusion distance, which is effective for increasing the permeability of substances such as physiologically active substances and nutrients

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS20250276111A1Immunoisolation device
Publication Date: 2025.09.04 KURARAY CO LTD
  • US20250276111A1 patent drawing
  • US20250276111A1 patent drawing
  • US20250276111A1 patent drawing

AI summary

An immunoisolation device that reduces diffusion distance, which is effective for increasing the permeability of substances such as physiologically active substances and nutrients, and has improved durability to withstand long-term transplantation. The immunoisolation device includes a sheet-like cell aggregate containing cells and an extracellular matrix, and an immunoisolation layer that covers the cell aggregate.